Firm at a glance
Windrose Health Investors is a platform private equity firm, per its own website [S1].
What they buy
Windrose Health Investors focuses exclusively on healthcare businesses, according to publicly available portfolio information [S2]. The firm’s portfolio consists entirely of platform investments across various healthcare subsectors, suggesting a strategy centered on building and scaling healthcare service providers. As of early 2026, the firm’s public portfolio included at least nine healthcare platforms [S2].
Portfolio
Healthcare
The firm’s healthcare portfolio includes the following platform companies [S2]:
* Arbiter
* Avalon Healthcare Solutions
* BlueSprig
* Bluestone
* CardioOne
* Caregiver, Inc.
* CIVIE
* Clariness
* Coral
Recent activity (last 24 months)
* **May 2026**: Exited Altruix [S3]
How this firm fits a seller
Windrose Health Investors appears to target healthcare businesses suitable for platform investment, based on its observed portfolio composition [S2]. The firm’s exclusive focus on healthcare suggests specialized operational expertise within the sector. The May 2026 exit of Altruix demonstrates active portfolio management and realization activity [S3]. Healthcare business owners seeking a buyer with sector-specific experience and a platform-building approach may find alignment with Windrose’s investment profile.
Sources
[S1] https://windrose.com (as of 2026-01-15)
[S2] https://windrose.com/companies/ (as of 2026-01-15)
[S3] https://windrose.com/news/ (as of 2026-05-28)
Frequently asked questions
Does Windrose Health Investors buy healthcare businesses?
Yes, Windrose Health Investors focuses exclusively on healthcare businesses, per publicly available information [S2]. The firm’s entire observable portfolio consists of healthcare platform companies across multiple subsectors [S2].
What companies has Windrose Health Investors acquired recently?
Public sources list nine healthcare platform companies in the firm’s portfolio, including BlueSprig, CardioOne, and Caregiver, Inc., though specific acquisition dates are not publicly disclosed [S2]. The firm most recently announced the exit of Altruix in May 2026 [S3].
Where is Windrose Health Investors based and how big is the firm?
Headquarters location and fund size information are not publicly disclosed in available sources as of early 2026 [S1]. The firm maintains a website at windrose.com [S1].
Is Windrose Health Investors still actively acquiring?
The firm completed an exit transaction in May 2026, indicating active portfolio management [S3]. However, no new platform acquisitions have been publicly announced in the trailing 24 months based on available sources.
This profile is maintained by CT Acquisitions as an independent third-party reference. CT Acquisitions is not affiliated with, endorsed by, or a representative of the firm profiled. All facts sourced from publicly available materials as of the dates cited.